NDLI: The high price of 'free' trade: U.S. trade agreements and access to medicines.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Lopert, Ruth Gleeson, Deborah
Spatial Coverage	United States Australia Republic of Korea
Description	Author Affiliation: Lopert R ( George Washington University.)
Abstract	The United States' pursuit of increasingly TRIPS-Plus levels of intellectual property protection for medicines in bilateral and regional trade agreements is well recognized. Less so, however, are U.S. efforts through these agreements to influence and constrain the pharmaceutical coverage programs of its trading partners. Although arguably unsuccessful in the Australia- U.S. Free Trade Agreement (AUSFTA), the U.S. nevertheless succeeded in its bilateral FTA with South Korea (KORUS) in establishing prescriptive provisions pertaining to the operation of coverage and reimbursement programs for medicines and medical devices, which have the potential to adversely impact future access in that country. More recently, draft texts leaked from the current Trans Pacific Partnership Agreement (TPPA) negotiations show that U.S. objectives include not only AUSFTA-Plus and KORUS-Plus IP provisions but also ambitious inroads into the domestic health programs of its TPPA partners. This highlights the apparent conflict between trade goals - pursued through multilateral legal instruments to promote economic 'health'- and public health objectives, such as the development of treatments for neglected diseases, the pursuit of efficiency and equity in priority setting, and the procurement of medicines at prices that reflect their therapeutic value and facilitate affordable access.
File Format	HTM / HTML
ISSN	10731105
Issue Number	1
Volume Number	41
e-ISSN	1748720X
Journal	The Journal of Law, Medicine & Ethics
Language	English
Publisher	Sage Publications
Publisher Date	2013-01-01
Publisher Place	Great Britain (UK)
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Jurisprudence Discipline Medicine Commerce Legislation & Jurisprudence Drug Industry Health Services Accessibility International Cooperation Patents As Topic Pharmaceutical Preparations Economics Australia Drug Costs Humans Negotiating Republic Of Korea United States Journal Article
Content Type	Text
Resource Type	Article
Subject	Issues, Ethics and Legal Aspects Health Policy

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health.

Introduction: Pharmaceutical firms and the right to health.

Introduction: pharmaceutical innovation: law & the public's health.

Human rights responsibilities of pharmaceutical companies in relation to access to medicines.

Patents and human rights: a heterodox analysis.

Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.

Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.

The ethics of intellectual property rights in an era of globalization.

An economic justification for open access to essential medicine patents in developing countries.

The high price of 'free' trade: U.S. trade agreements and access to medicines.

Similar Documents

Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health.

Introduction: Pharmaceutical firms and the right to health.

Introduction: pharmaceutical innovation: law & the public's health.

Human rights responsibilities of pharmaceutical companies in relation to access to medicines.

Patents and human rights: a heterodox analysis.

Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.

Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.

The ethics of intellectual property rights in an era of globalization.

An economic justification for open access to essential medicine patents in developing countries.

The high price of 'free' trade: U.S. trade agreements and access to medicines.